Nanostructured transdermal hormone replacement therapy for relieving menopausal symptoms: a confocal Raman spectroscopy study
Marco Antonio Botelho, Dinalva Brito Queiroz, Gisele Barros, Stela Guerreiro et al. • Clinics
(2014)
OBJECTIVE: To determine the safety and efficacy of a transdermal nanostructured formulation of progesterone (10%) combined with estriol (0.1%) + estradiol (0.25%) for relieving postmenopausal symptoms. METHODS: A total of 66 postmenopausa...
DOAJ
Open Access (DOAJ)
DOI:
10.6061/clinics/2014(02)01